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ABSTRACT

DEVELOPMENT OF A METHOD TO EXAMINE
SHEAR STRESS ON CARDIOMYOCYTES
by
Dhawal Desai
Cardiac hypertrophy is the remodeling or enlargement of the heart exhibited by
individuals suffering from heart disease. Cardiac hypertrophy involves two mechanisms,
mechanical stresses and humoral changes in the cardiac tissue. One such humoral change
involves the Renin Angiotensin System (RAS). The primary function of RAS is
maintenance of hemodynamics of the body mediated through an effector protein,
Angiotensin II. However, RAS has been shown to play a significant role in the
pathophysiology of the heart; contributing to hypertension, cardiac hypertrophy and
myocardial infarction. RAS acts through binding of Angiotensin II at its receptors. The
two forms of Angiotensin II receptors, designated type one (AT 1) and type two (AT2),
have been shown to have different functions and distribution in various body tissues.
Receptors for both AT1 and AT2 are expressed on cardiomyocytes. The level of
expression of each receptor type has been shown to have important implication. It has
been suggested that the receptors may have cooperative yet opposing effects when bound
by Angiotensin II. Thus, the level of expression may drive the system to or away from
hypertrophy.
The current research developed techniques to allow examination of the hypothesis
that in cardiomyocytes, exposure to increasing shear stress causes upregulation of the
AT1 and AT2 receptors. The isolated rat cardiomyocytes were exposed to shear stress

and methods were developed to measure the change in AT1 and AT2 cellular expression
resulting from the application of shear stress. The techniques required to accomplish this
task including isolation of rat cardiomyocytes, flow chamber (shear stress) apparatus and
use, handling of cardiomyocytes and molecular science techniques (RT-PCR) are
described here in detail. The ability to track gene regulation of AT1 and AT2 receptors
though RT-PCR techniques is demonstrated. The ability to attach cardiomyocytes to a
culture dish surface in order to expose them to shear stress is also shown. However, to
take full advantage of the flow chamber, stronger cell attachment to culture dish is
required. Future research will be directed to achieving stronger adhesion between
cardiomyocytes and the cell culture surface. Recent reports have suggested use of
various culture surfaces and adhesion molecules including laminin, elastin, cell culture
plastic, and fibronectin. Use of serum and serum free medium has also been suggested.

DEVELOPMENT OF A METHOD TO EXAMINE
SHEAR STRESS ON CARDIOMYOCYTES

by
Dhawal Desai

A Thesis
Submitted to the Faculty of
New Jersey Institute of Technology
In Partial Fulfillment of the Requirements for the Degree of
Master of Science in Biomedical Engineering
Department of Biomedical Engineering
May 2002

APPROVAL PAGE
DEVELOPMENT OF A METHOD TO EXAMINE
SHEAR STRESS ON CARDIOMYOCYTES
Dhawal Desai

Dr. Arthur B. Ritter, Thesis Advisor
Associate Professor of Pharmacology and Physiology, UMDNJ

Date

Dr. Stanley S. Reisman, Committee Member
Professor of Biomedical Engineering, NJIT

Date

Dr. Ronald H. Rockland, Committee Member
Date
Associate Professor of Engineering Technology and Biomedical Engineering, NJIT

BIOGRAPHICAL SKETCH

Author:

Dhawal Desai

Degree:

Master of Science in Biomedical Engineering

Date:

May 2002

Undergraduate and Graduate Education:
•

Master of Science in Biomedical Engineering
New Jersey Institute of Technology, Newark, NJ 2002

•

Bachelor of Art, Biological Sciences
Rutgers, The State University of New Jersey, Newark, NJ 1998

Major:

Biomedical Engineering

To my family.

vi

ACKNOWLEDGEMENT

I want to express my many thanks to Dr. Arthur Ritter for his guidance in my research.
The past year has been long and arduous. I want to thank him for keeping me dedicated,
motivated and in the process teaching me to be patient. It is a great lesson not only in
science but also in life. I would also like to express my thanks to Dr. Stanley Reisman
for fulfilling his double duties as my instructor and an excellent faculty advisor. I want to
thank Dr. Ronald Rockland and Dr. Michael Lacker, their classes opened up new avenues
and experiences that will foster my learning beyond the classroom. I also want to thank
everyone in Dr Andrew Thomas' laboratory at University of Medicine and Dentistry for
allowing me to work in their laboratory and assisting me in every way possible.
I want to express my gratitude to Mr. Taral Oza and Mr. Niraj Kher for being
excellent friends and classmates. Your timely assistance was greatly appreciated.
I want to thank my friends and family for their support, motivation and guidance.
I am lucky to have you all.
Finally, I like to thank God. Without His guidance not much is possible. I pray
for His continued guidance and blessings in all of my future endeavors.

vii

TABLE OF CONTENTS
Chapter

Page

1 INTRODUCTION

1

1.1 Cardiac Hypertrophy

1

1.2 Renin Angiotensin System

1

1.3 Therapies against Cardiac Hypertrophy

2

1.4 Angiotensin Receptors and Actions

3

1.5 Signal Transduction Pathways

5

1.6 Current Research

6

2 MATERIALS AND METHODS

8

2.1 Isolation of Cardiomyocytes

8

2.1.1 Materials

8

2.1.2 Procedure

9

2.1.3 Cell Isolation

11

2.2 Messenger RNA Isolation by Rneasy Mini Kit (From Qiagen®, #74104)....

11

2.3 RT-PCR

13

2.4 Cell Attachment and Flow Chamber Procedure

17

2.4.1 Materials

17

2.4.2 Procedure

18

3 RESULTS

21

3.1 RNA Extraction and RT-PCR

21

3.2 Cardiomyocytes

22

3.3 Cell Attachment

viii

24

TABLE OF CONTENTS
(Continued)
Chapter

Page

3.4 Shear Stress

4

25

3.4.1 What is shear stress?

25

3.4.2 Calculation of shear stress at the wall

25

DISCUSSION

30

5 CONCLUSIONS AND RECOMMENDATIONS
REFERENCES

ix

33

34

LIST OF TABLES
Page

Table
2.1
2.2

RT
RT

Cocktail
Cycle

2.3 PCR Cocktail

13
14
14

2.4 Cycle for AT1

15

2.5 Cycle for AT2

15

2.6 Cycle for Housekeeping Gene GAPDH

15

3.1 Shear Stresses

27

LIST OF FIGURES
Figure

Page

2.1

Langendorff apparatus

2.2

General diagram for flow experiments

3.1

Gel electrophoresis of AT1 gene

3.2

Gel electrophoresis of AT2 gene

3.3

Cardiomyocytes....

10
20
21
21
22

3.4a Cardiomyocyte fully extended

23

3.4b Cardiomyocyte in contraction

23

3.4c Cardiomyocyte in extension

23

3.5

Cardiomyocyte attached to polystyrene surface

24

3.6

Cardiomyocyte attached to the membrane

24

3.7

The flow chamber

27

3.8a-d Fluid movement through the flow chamber

xi

29

CHAPTER 1
INTRODUCTION
1.1 Cardiac Hypertrophy
Individuals with cardiac complications such as hypertension and myocardial infarction
exhibit cardiac hypertrophy. Hypertrophy or enlargement of the cardiac tissue is an
adaptive response to mechanical stresses placed on the heart by existing cardiac disease.'
The mechanical overload causes terminal cardiomyocytes to enlarge. Cell enlargement is
followed by remodeling events that include loss of cardiomyocytes, production of
fibroblasts and deposition of collagen.' All of these processes lead to loss of compliance
and further deteriorate the cardiac system increasing the chances of heart failure. The
mechanisms for cardiac hypertrophy are complex and not completely understood.
However, research has shown that mechanical overload and humoral factors are two
pathways having great influence over the development of cardiac hypertrophy. The
Renin Angiotensin System (RAS) is one of the humoral systems implicated in the
pathogenesis of cardiac hypertrophy.

1.2 Renin Angiotensin System
The primary function of the Renin Angiotensin System (RAS) is maintenance of
hemodynamics in the body. It accomplishes this via salt retention in the kidney as well
as vasoconstriction. However, this thesis the focus will be on the effects of RAS as they
relate to the development of cardiac hypertrophy. It is well established that RAS through
Angiotensin II (Mg II) plays a significant role in the pathophysiology of the cardiac
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system, contributing to hypertension, cardiac hypertrophy and myocardial infarction."
Angiotensin II is produced in various tissues and through many different pathways that
seem to be species specific. 2 The dominant pathway in Angiotensin II production is
through Angiotensin Converting Enzyme (ACE). Angiotensin Converting Enzyme
converts Ang I into Ang II, the molecule credited with RAS activity. However, an
alternative pathway through the chymase group of enzymes has demonstrated production
of Angiotensin II in the presence of ACE inhibition. 2 In vivo studies, however, credit the
majority of Angiotensin II production to the ACE dependent pathway. The activity of
Angiotensin II has been well documented. A recent report has shown that increased local
expression of the octapeptide Ang II leads to cardiac hypertrophy. 3 The technique
involved transfection of Human Angiotensin Converting Enzyme (ACE) into cardiac
myocytes. The initial release of Ang II leads to a self-stimulation event, where the
release of Ang II causes vasoconstriction leading to increase in pressure. Increase in
pressure leads to further production of Ang II and further deterioration of cardiac tissue.
The action of Ang II occurs through its binding to Ang II specific receptors. A short
discussion on the therapeutic interventions is presented here before beginning an in-depth
look at Ang II receptor mediated effects on the cardiac system.

1.3 Therapies against cardiac hypertrophy
Two therapeutic interventions aimed at prevention of cardiac hypertrophy have been
proposed. One of the methods looks at the production of Ang II. Since ACE is the
dominant pathway leading to Ang II production in the body, this method aims to inhibit
ACE activity. ACE blockers have shown to be effective in reducing patient mortality and

3

morbidity by reducing Ang II production. 4 ' 5 However, complete suppression through
ACE inhibition has not been achieved nor is it considered possible. As shown earlier,
multiple sources and multiple pathways are responsible for production of Ang II in the
body. In fact, it has been shown that in cases where ACE inhibitors have been utilized
alone the level of systemic Ang II returns to normal levels through other production
pathways.
The second mode of intervention aims at prevention of Ang II binding to its
receptors. Initial studies with Losartan, an Ang II receptor antagonist, have shown to be
cardio protective. However, researchers have suggested that combining these
approaches, including ACE and chymase inhibition and Ang II receptor antagonism, may
prove even more beneficial.

1.4 Angiotensin Receptors and Actions
The Angiotensin II receptors have been credited with various responses upon binding of
Ang II. Based on their affinity for receptor antagonists such as Losartan and PD 123177,
as many as five Ang II receptors have been identified. 6 Angiotensin II type 1 (AT1) and
Angiotensin II type 2 (AT2) receptors are credited with most of the functions resulting
from Ang II binding. A good overview of functions attributed to these two Angiotensin
receptors is presented by Busch et al 2000. 7 AT1 mediates all hemodynamic functions,
including vasoconstriction, renal salt retention and release of aldosterone and vasopresin.
The hypertrophic response to Ang II is also thought to be though AT1 receptor via
growth factor p1 and endothelin-1. A great debate is taking place over the role of AT2.
One group claims a counter-balancing role between the two receptors with AT1 causing
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the pathological effects observed in cardiac hypertrophy and AT2 demonstrating a cardio
protective role. 8 Through the use of type selective antagonists, they demonstrated that
growth or antigrowth response is a consequence of receptor density rather than level of
Ang II present. The second group of researchers believes that there is little evidence to
substantiate the claim that AT2 restores cardiac health by counteracting the effects of
Ang II binding to AT1 receptors. Meanwhile, other researchers believe further
investigation is required to bring a conclusion to the debate.9' 10
The receptor story, however, is much more complex. Along with the functions of
each receptor the issues of tissue expression and receptor density must also be
considered. The expression of these receptors is both tissue and species specific. 11-15 It
has been reported that adult rat cardiac cells only express AT1 binding sites whereas in
human myocardium the level of AT2 receptors dominates with a two to one ratio. 16
Furthermore, AT1 and AT2 expression is regulated developmentally and therefore tends
to fluctuate. The number of AT2 receptors tends to decline after birth to a lower
number. 13 ' 17 Finally, in a failing heart or infarcted hearts the AT1 and AT2 receptors are
selectively upregulated. 18 Specifically, in an infarcted animal the number of AT1
receptors decreases while the number of AT2 receptors shows an increase one-day post
infarction. Other studies involving failing human hearts have shown that AT1 expression
decreases while AT2 remains unchanged, causing a relative increase in the level of AT2
receptors.
The reason for placing emphasis on receptor expression here is because this may
be the driving force behind Ang II mediated remodeling of the heart. If Kestern and
group are correct about a cooperative relationship between Ang II type 1 and 2 receptors
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and their claim that receptor density is more important than levels of Ang II, it will have a
profound effect on the future direction of research and treatment. Studies are continuing
and no consensus has been reached.

1.5 Signal Transduction Pathways
This section looks at the down stream effects of Ang II binding to its receptors. It is
believed that Ang II mediated hypertropic response may involve more than one signal
transduction pathway. It has been shown that binding of Ang II to its receptors invokes
second messengers such as Inositol Triphosphate IP3, Ca 2+ and activation of G protein
coupled STAT/JAK Kinase and Protein Kinase C (PKC). McWhinney and group have
shown that in neonatal rat cardiomyocytes binding of Ang II to AT1 leads to formation of
sis-inducing factor (SIF) protein. 19 SIF occurs in three varieties SIF-A, SIF-B, SIF-C.
SIF-B consists of a heterodimer of activated Stat 1 and Stat3 proteins and SIF-A and SIFC are homodimers of Stat3 and Stat 1 respectively. The activation of Stat proteins
involves phosphorylation of a tyrosine residue, which takes place through JAK tyrosine
Kinase activity. Inhibition of JAK or tyrosine kinase activity prevents SIF complex
formation. SIF complex translocates to the nucleus, binds SIE element and promotes
transcription of downstream genes. The same group also reported a JAK dependent
Prolactin Inducing Factor (PIF). 2° PIF results from a complex formed between Stat5a
and Stat5b proteins that subsequently translocate to the nucleus and influence
transcription. All of these proteins also exhibit ability to bind the AT1 receptor. It is
thought that binding of Ang II to the AT1 receptor leads to activation of the receptor
bound JAK kinase, followed by activation and translocation of Stat proteins. Ang II
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binding to AT2 does not result in JAK/STAT transduction event. However, pressure
overloaded rat heart remodeling events involve the JAK/STAT transduction pathway. In
overloaded hearts, an early and late response is observed. The early response is mediated
by pressure directly and the late response results from pressure induced release of Mg
/1. 21

Research also exists to show that hypertrophic response to Mg II is directed
through a Ca2+ related signaling pathway. In adult rat cardiomyocytes, the increase in
Ca2+ is mediated equally through both AT1 and AT2 receptors. 22 Others have reported
that cardiac hypertrophy is mediated by Ca 2+ activation of PKC that leads to induction of
early gene such as c-fos. 23 They also showed that Ca 2+ , AT1, and PKC inhibition leads to
suppression of mRNA and protein synthesis in cardiomyocytes. The details of AT2
activation and signal transduction have not yet been reported. Significant evidence
however is present to conclude that binding of Mg II to AT1 results in downstream
signal transduction and protein synthesis responsible for the hypertrophic response in
cardiomyocytes. Further investigation is required to determine the AT2 transduction
pathways and the role of these various pathways leading to a hypertropic response
via AT 1 receptor.

1.6 Current Research
The aim of the current research was to develop techniques that would allow testing of the
hypothesis that in cardiomyocytes, an increased exposure to shear stress leads to
upregulation of AT1 and AT2 receptors. As shown in section 1.4, the receptors play a
significant role in development of cardiac hypertrophy. For the experiments performed
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for this thesis, a flow chamber was used to generate varying velocities of a fluid through
the flow chamber. A detailed discussion of the flow chamber is presented in the
materials and methods section. In the same section, the rat cardiomyocytes isolation
procedure, shear stresses within the flow chamber and cell culture procedures for
handling cardiomyocytes are discussed. Finally, the preliminary findings are presented
and the future direction of research is suggested.

CHAPTER 2
MATERIALS AND METHODS
The experiment is complex and requires many steps to complete. For convenience, the
methods section is divided into four parts. These include: isolation of cardiomyocytes,
messenger RNA (mRNA) extraction, RT-PCR and cell culture procedure as well as steps
involved in exposing the cardiomyocytes to shear stress.

2.1 Isolation of Cardiomyocytes
For the experiment, Sprage-Dawley rats weighing between 175-200 grams were used.
Cells were isolated using an enzymatic method described previously by Mitra and
Morad. 24 The following materials and solutions are required for the isolation technique.
2.1.1 Materials
1. Zero Ca+2 — Langendorff solution
2. 50 mM CaCl2
3. Collagenase (Worthington Biochemical Corporation, Lakewood, NJ 08701)
4. Protease (Sigma Chemical Com. Louis, MO 63178)
5. Pentobarbital (Veterinary Laboratories Inc. Lenexa, KS 66215)
6. Surgical Instruments:
Large scissor (1)

Small scissor (l)

Artery clip (l)

Hemostat (l)

Small dish (l)

Suture
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Stock Solutions are prepared in advance:
Zero Ca+2 — Langendorff Solution pH of 7.2:
Add 135mM NaCI,
5.4mM KCl,
1mMgCl2 ,
0.33mM NaH2PO4,
10mM HEPES solution.
0.2mM Ca+2

-

Langendorff Solution:

The 0.2 mM Ca +2— Langendorff solution is prepared by adding 50mM CaCl2
solution to Zero Ca +2 - Langendorff Solution (1:250 dilution). Both Langendorff
solutions are titrated to pH 7.2.

2.1.2 Procedure
The water bath is turned on 30-45 minutes prior to animal sacrifice to warm the apparatus
to 37 degrees Celsius. Four to five 50ml eppendorf tubes are marked accordingly. The
Langendorff apparatus is readied by washing with 1 liter of deionized water 30 minutes
prior to sacrifice. The 0.2 mM Ca — Langendorff solution (250ml) is prepared and
warmed by placing in the water bath. The Zero Ca — Langendorff solution (100ml) is
also prepared. Then Collagenase (25mg) and Protease (5mg) are measured out and
placed in a small bottle or beaker. For these experiments the above amounts of Protease
and Collagenase proved best. However, depending on animal size and other factors these
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amounts are adjusted. The animal is anesthetized by administering 50-100 mg/kg dose
of pentobarbital.
Upon checking for pain reflexes, the heart is excised and placed in a small dish
containing Zero Ca — Langendorff solution. Then the heart is, placed on the apparatus by
cannulating the ascending aorta and perfused with 0.2 mM Ca — Langendorff solution at a
rate of 5-10 ml/min. The heart is secured in place with an artery clip and suture. A
small incision is made at the top of the heart to enable the heart to empty of blood and
Langendorff solution. Perfusion is continued until blood is completely removed from the
heart, approximately two to three minutes. At this point, flow is switched to Zero Ca —
Langendorff solution for 5 minutes. During this time, 25 ml of the warm Zero Ca —
Langendorff is added to the premixed enzymes and dissolved well. Then, the enzyme
solution is added to the chamber containing Zero Ca — Langendorff solution. Additional
Zero Ca — Langendorff solution is added to the chamber to bring the final volume to 50
ml. Perfusion is continued with the enzyme solution for five to seven minutes (5:15
yielded the best results).

Zero Ca Langendorff Sol

Figure 2.1 Langendorff apparatus.

0.2 mM Ca Langendorff Sol

11

2.1.3 Cell Isolation

The heart is removed from the apparatus and placed in a small dish containing
0.2 mM Ca — Langendorff solution. Any remaining arterial tissue is removed from the
heart. The heart is then minced gently but quickly. The minced tissue and solution are
transferred to a 50 ml eppendorf tube and placed in the water bath. They are left in the
bath only long enough for the tissue to settle to the bottom. The solution is decanted into
a beaker and saved. To the tissue remaining in the eppendorf tube, 10-12 ml of 0.2 mM
Zero Ca — Langendorff solution is added. The tube is placed in the water bath and
agitated gently every few minutes. After five minutes, the supernatant is decanted into the
first of the five effendorf tube and the process if repeated for the rest of the tubes. When
finished, the cells are checked under a microscope. The cells are then refrigerated at
20°C and allowed settle to the bottom on the tubes.

2.2 Messenger RNA isolation by RNeasy Mini Kit (From Qiagen®, #74104)

When ready, cells are removed from the refrigerator and mixed by slowly agitating each
tube. The cells are then combined and equal volumes are distributed into two balanced
tubes. The cells are spun down in a slow-speed centrifuge at the lowest rotation rate
available (<100 rpm) for two minutes. The supernatant is discarded and 175 1.11, RLN
solution (50mM Tris-Cl, pH 8.0; 140mM NaCl; l.5mM MgCl 2 ; 0.5% Nonidet p-40) is
added to the pallet. Cells are mixed with RLN solution by flicking the bottom of the tube.
The content is transferred to a new 2 ml tube and incubated for five minutes on ice. The
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mixture is then spun in a microcentrifuge in the cold room for two minutes at 2100 rpm.
In these experiments, the rest of the procedure is carried out in the cold room.
The supernatant is transferred to a new tube. To the supernatant, 600 µL RLT buffer
with P-Mercaptoethanol (10 ml RLT + 100 III, f3-Mercaptoethanol) is added and
vortexed. Then, 4301.11 of 100 percent Ethanol is added and mixed by pipeting. From the
mixture, 700 µL is placed on a RNeasy column in a 2 ml collection tube. The column is
centrifuged at 10,000 rpm for 30 seconds. The supernatant is discarded and the process is
repeated with the remaining sample. Next, 700 µL buffer RWl is pipeted into the
RNeasy column, and centrifuged at 10,000 rpm for 30 seconds to wash. The RNeasy
column is then transferred into a new 2 ml collection tube. Buffer RPE (500 µL) is
pipeted into the RNeasy column, and centrifuged at 10,000 rpm for 30 seconds to wash.
Then 500 µL buffer RPE is pipeted into RNeasy column, and centrifuged at 14,000 rpm
for two minutes to dry the RNeasy membrane. The RNeasy column is placed in a new
1.5 ml collection tube and 30-50 µL of Rnase-free water is pipeted directly onto the
RNeasy membrane. The RNeasy column is then centrifuged for one minute at 10,000
rpm to elute. The last step is repeated if the expected mRNA yield is more than 30 1.1g.
The Optical Density (OD) is checked on a spectrophotometer by diluting two 1.1I, of the
sample with 98 1.1,L of Rnase-free water. The mRNA ratio = Abs at 260nm/ Abs at 280
should be between 1.8- l.99. The mRNA concentration in lug mRNA/ml= Abs at 260nm
* 40* 100(dilution factor). The extracted mRNA is stored in the -80 °C refrigerators.

13

2.3 RT-PCR
The frozen mRNA is thawed by warming between the hands. After labeling aliquoted
tubes, 20 µL of thawed mRNA is placed into each tube. If using internal standard
mRNA, serial dilutions are prepared as required. The RT "Cocktail" is prepared
according to Table 2.l below (all materials should be stored at —20°C but thawed before
use).
Table 2.1 RT Cocktail
Cocktail*

Volume needed for 40 µL Volume for 5.5 samples
(.1L)
of reaction mixture (µL)
25 mM MgCl2
8
44
10x PCR Buffer
4
22
10 mM dNTP
16
88
Rnase Inhibitor
2
11
Oligo d(T)
2
11
Rnase-free H20
2
11
Mulv RT
2
11
Random Hexamers
2
11
Total
38
209
* All cocktails prepared assuming starting with 0.5 µg/µL RNA

Internal standard dilutions are denatured at 65°C for 5 min. Five PCR tubes are prepared
for each mRNA sample and then 19 4, of cocktail is placed in each tube, with one of the
dilutions of the internal standard in each tube. Each tube is labeled and placed in the
PCR reaction plate and covers are snapped on. Automatic RT cycle is run according to
the time and temperature indicated in Table 2.2.
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Table 2.2 RT Cycle
Cycle
Temerature (°C)
Time (min)

_ 1
42
60

2
95
5

3
4
hold

Upon completion of the cycle, the tubes are removed. Prior to beginning PCR, the PCR
"Cocktail" is prepared by adding materials in the amount specified below in Table 2.3.

Table 2.3 PCR Cocktail
Cocktail*
25 Mm MgCl2
10x PCR Buffer
10 mM dNTP
Taq DNA Polymerase
Distilled H20
Total

Volume needed for 45 0.,
of reaction mixture (A)
2
4
l.6
0.25
35.15
43

Volume for
(4)
32
64
25.6
4
562.4
688

16 samples

Then, 43 A of PCR cocktail, 1 111_, of the 3' and 5' primers and 5 A of mRNA sample
(Product from RT) are placed in a new PCR tubes (Total =50 µL). The primers are short
nucleotide sequences 10-20 base pairs long that bind a specific DNA sequence. DNA
polymerase will recognize the bound primer as the start point of transcription and will
synthesize a copy of the original sequence. Each tube is labeled and placed in the PCR
reaction plate with the covers snapped securely. One of the following automatic PCR
cycle is run based on the gene amplification desired. 7
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AT1 primer sequence
5'- cagcttggtggtgattgtc
3'- gccatcggtattccatagc

Table 2.4 Cycle for AT1
2 (63X)
72
94
57
.45
.45
.45

1
94
2.45

Cycle
Temperature (°C)
Time (min)

3
72
7

AT2 primer sequence
5'- tagtctctctcttgccttgg
3'- ctgaccttcttggatgctct

Table 2.5 Cycle for AT2
Cycle
Temperature (°C)
Time (min)

1
94
5

94
.45

2 (70X)
63
1.45

72
2.10

3
72
10

GAPDH primer sequence
5' - ttcaccaccatggagaaggc
3' - ggcatggactgtggtcatga

Table 2.6 Cycle for Housekeeping Gene GAPDH
Cycle
Temperature (°C)
Time (sec)

1
95
6

95
20

2
61
30

73
30

3
73
5

16

The Housekeeping (GAPDH) gene serves as a positive control in these
experiments. Due to its abundance in the cell it is easily transcribed. Therefore, the
absence of the Housekeeping signals that an error in either process or technique has taken
place. In order for the RT-PCR technique to work, the error has to be found and
corrected.
An agarose gel (1.2 %) is prepared by adding l.2 grams of Agarose into 100 ml of
1X TEA buffer. The solution is boiled so that all of the Agarose dissolves. When all the
agarose is dissolved, the solution is cooled until comfortable to touch. Then, the solution
is poured into the casting unit and 2 !IL of Ethidium Bromide is added (Toxic, wear
gloves when handling it). The lane comb is put in place and the gel is allowed to solidify.
Enough 1X TAE running buffer is added to cover the gel completely. The PCR tubes are
removed from the PCR system. A piece of parafilm is set up and labeled in a similar way
as the tubes. At each position, two }IL of loading dye and 12 of corresponding sample
are placed. Before loading samples into wells, the dye and the sample are thoroughly
mixed on the parafilm. While preventing air bubbles from entering, the sample is pipeted
off the parafilm. The tip is placed into a well and slowly the sample is inserted. The
power source is connected and the gel is run at 100V for 45 minutes. Once completed,
the gel is removed immediately so the buffer does not fade the bands. An appropriate
UV light imaging system is used for viewing the bands on the gels.
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2.4 Cell Attachment and Flow Chamber Procedure
2.4.1 Materials
The following items are required to carry out the cell attachment and flow experiments.
35 mm Tissue Culture Dish Polystyrene (Corning Glass Works, Corning, NY, 14831)
Becton Dickinson (B-D) Falcon Cell Culture Inserts pore size 1 gm (Fisher Scientific
Company, Pittsburgh, PA 15219)
Inverted-stage microscope
Objective lens (6.3 x, 10 x, 22 x, 40 x)
Cardiomyocytes obtained from cell isolation procedure
Computer with interface to imaging system
Flow chamber deck with gasket and tube fittings (GlycoTech, Rockville, MD 20850)
Syringe Pump Model '33' (Harvard Apparatus Inc. Holliston, MA 01746)
Syringes to fit on the pump (10cc, Becton Dickinson & Co, Franklin Lakes NJ 07417)
Silastic tubing for syringe and flow chamber (ID 1/8" OD 3/16" Fisher Scientific
Company, Pittsburgh, PA 15219)
Vacuum pump
Display monitor
Video recorder (SVHS)
SVHS videocassette
Video Camera
Culture dish restraint (designed internally to prevent culture dish movements while on the
microscope stage)
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2.4.2 Procedures
Upon isolating cardiomyocytes by the methods described previously, approximately 3ml
of Langendorff solution containing cardiomyocytes is placed on a 35 mm culture dish.
Equal volume is also placed on a cell culture insert. The culture dishes are covered and
allowed to incubate at room temperature for three hours. The interval of three hours was
most suitable for attachment. Intervals shorter than three hours were not sufficient for
cell attachment and intervals longer than three hours did not translate into stronger
attachment. Overnight incubation was also attempted; however, most cells did not
survive the incubation period and attachment of remaining cells was not improved
significantly.
Prior to starting assembly for the flow chamber, 0.9% saline solution of pH 7.4 is
prepared and placed in 37°C water bath. Next, the flow apparatus is assembled as
follows. The tubing is attached to the syringe and filled with 0.9% saline solution that
will be used as the flow medium in these experiments. All the air is evacuated from the
syringe and the tubing. Then, the syringe is secured to the pump by following the
instructions in the pump's user manual. Next, the inlet, the outlet and the vacuum lines
are connected to the flow chamber deck and the vacuum is turned on. The culture dish
containing cardiomyocytes is secured to the inverted-stage microscope by the culture dish
restraint. Next, the pump is turned on and the desired fluid rate and syringe size are
selected. It is also recommended that the pump be calibrated when initially received.
Again, before placing the flow chamber deck into the culture dish all air bubbles that may
have entered the apparatus are evacuated. At this point, the gasket is placed onto the
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deck and the pump is run for a few seconds so that there is a small amount of medium in
the flow path; this ensures that no bubbles are produced when the deck is placed into the
culture dish. Next, excess medium is removed from the culture dish. This will also
remove unwanted debris and dead cells. Then while the vacuum is engaged, the chamber
deck is slowly lowered into the culture dish. The culture dish and flow chamber are then
secured in place with the microscope stage clamps and the flow is initiated. The
microscope is turned on and image acquisition is started at the desired magnification.
A similar procedure is used for the culture inserts. After incubating the cells for
three hours, the membrane from the culture insert is cut out and placed on the inverted
flow chamber deck. Next, air bubbles that may have entered between the deck and the
membrane are carefully removed. While holding the deck and membrane in the inverted
position, a clean 35 mm culture dish is placed on the deck. Once the flow chamber, the
membrane and the dish are secured onto the microscope deck, the flow and image capture
are initiated. A diagram of the general set up is presented below.
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Figure 2.2 General diagram for flow experiments

CHAPTER 3
RESULTS
3.1 mRNA Extraction and RT-PCR
To extract mRNA from cardiomyocytes, the Quigen® Mini Kit was utilized.
Cardiomyocytes were obtained from Sprage-Dawley rats through the cell isolation
method described before. Through the use of the reagent provided in the kit, mRNA was
consistently extracted in the range of 2.8 µg/ml. Upon isolation, the mRNA was stored at
-80° C to prevent degradation.
Next, RT-PCR was carried out with receptor specific primers and receptor
specific PCR cycles. Figure 3.1 below shows gel electrophoresis results of the AT1
amplified signal. A single strong band corresponding to AT1 in the range of hundreds of
base pairs was obtained. Similarly, the AT2 gene was also amplified. Using AT2 specific
primers and PCR cycle a single strong band for AT2 was obtained as seen in Figure 3.2.
In Figure 3.2 a smeared band corresponding to the AT1 gene can also be seen. The AT1
signal is smeared because an AT2 specific PCR cycles was used during the amplification
process that lead to fragmented copies of the AT1 gene.
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3.2 Cardiomyocytes
Prior to looking at cell attachment, a brief introduction to cardiomyocytes is presented
here. Figure 3.3 below presents both healthy and dead cardiomyocytes. The four cells
toward the right of the figure show the characteristic rectangular morphology and
striations of a live cardiomyocyte. The figure also shows a dead cardiomyocyte towards
the left that is characterized by the loss of both the striation and the rectangular
morphology.

Figure 3.3 Cardiomyocytes
Another characteristic of a live cardiomyocyte is its ability to contract.

In

Figures 3.4(a-c), a cell undergoing contractions is presented. Figure 3.4a shows the cell
in its resting stage, fully extended. As the contraction continues, the cell begins to
shorten. Figure 3.4b shows the cell in its contracted state. After contracting fully, the
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cell begins to elongate again and reaches the resting state in Figure 3.4c. For illustration
purpose, a line has been drawn on these figures representing the resting state. With the
aide of the line, it becomes easy to observe the cell contract and fully elongate again.

Figure 3.4a Cardiomyocyte

Figure 3.4b Cardiomyocyte

fully extended

in contraction

Figure 3.4c Cardiomyocyte
in extension
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3.3 Cell Attachment

In order to conduct flow experiments, first the cardiomyocytes need to be attached to the
culture dish. Two surfaces were selected to for this purpose. The first was a polystyrene
culture dish from Corning. Cells were incubated in the culture dish for three hours and
allowed to settle to the bottom and bind to the surface. Figure 3.5 shows a cardiomyocyte
bound to the polystyrene surface of the culture dish. Cells were also incubated in the cell

Figure 3.5 Cardiomyocyte attached
to polystyrene surface

Figure 3.6 Cardiomyocyte attached to
the membrane

culture inserts from Becton Dickinson. Cells were incubated and allowed to settle onto
the membrane of the insert. Figure 3.6 shows a cardiomyocyte attached to the membrane
of the culture insert. Once the cells had attached to the surface, the flow chamber
apparatus was set up according to the procedures presented in the methods section of this
paper. Upon completing the set up procedure, flow was initiated and cells were
monitored and recorded on videotape.
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3.4 Shear Stress
3.4.1 What is shear stress?
In a laminar flow chamber, the shear stress (force/area) acting on a fluid element by
adjacent fluid elements is opposed by the drag force caused by the intramolecular
attractive forces of the fluid (viscosity p.). The shear stress in a flowing fluid is maximal
at the walls. Since the cardiomyocytes are attached to the walls of the flow chamber,
they are subject to the maximal shear stress.

3.4.2 Calculation of shear stress at the wall
Based on the dimensions of the slit and the velocity of the medium, shear stress is
calculated as described by Bird et al. 25 For laminar flow in a slit of dimensions
B (thickness), W (width) and L (length), a steady state momentum balance on the fluid
yields equation 3.1 relating shear stress τx z as a function of pressure difference AP. Then
Newton's law of viscosity, equation 3.2, is substituted for T x, and the resulting
relationship is integrated to give the velocity distribution (V i) in the slit, equation 3.3.
Since flow is the measured quantity, flow is calculated as average velocity <vx> times slit
area. The average velocity is obtained by integrating the velocity distribution over the
cross-sectional area of the slit to give equation 3.4. From equation 3.4, AP/L (which is
not measured) can be eliminated from equation 3.1 to give the shear stress in terms of the
flow (Q), which is the measured quantity. This is given by equation 3.5 below.
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The flow chamber is formed by sandwiching a rubber gasket between the flow
chamber deck and the surface of the culture dish as illustrated by Figure 3.7. A
rectangular slit is cut in the gasket to provide the path for the fluid to move through the
chamber. Along with the flow chamber, four gaskets of varying width and thickness
were provided. In these experiments, a single gasket of width 0.25 cm and thickness of
0.010 inch was utilized. By using the formulas above, shear stresses through the chamber
were calculated. The shear stress values for the two flow rates used in these experiments
are provided in Table 3.l. As specified above, the thickness of the path (B) was assumed
to be 0.010 inch and width (W) was assumed to be 0.25 cm. For ease of calculation,
viscosity (g) of the medium was assumed to equal one centipoises, the viscosity of water.
For this thesis, experiments were conducted with flow rates of 10 ml and 20 ml per hour.
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At 10 ml/hr flow rate, the cells remained attached for two minutes and nine seconds on
the polystyrene surface and fourteen minutes and eleven seconds with the membrane
from culture inserts. For experiments with flow rate of 20 ml/hr, the longest duration that
cells remained attached was nineteen minutes and twenty seconds on the polystyrene
surface. No experiments were conducted at 20ml/hr using membrane from culture inserts.
Vacuum
Line

Figure 3.7 The flow chamber

Table 3.1 Shear Stresses
Flow Rate Q

Shear Stress τ xz

10 ml/hour

.258 dynes/cm2

20ml/hour

.516 dynes/cm2
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To illustrate flow through the flow chamber, Figures 3.8(a-d) are presented
below. The figures present a live cardiomyocyte attached to the surface while another
cell passes through the flow chamber. In Figure 3.8a the nonattached (free) cell is just
entering the visible area as the attached cell remains adhered to the surface. In Figures
3.8b and 3.8c the free cell can be seen coming in contact with the adhered cell while
passing though the flow chamber. Finally, in Figure 3.8d, the cell is seen exiting the
visible window. The figures document the presence of flow through the flow chamber
and ability of cardiomyocytes to remain attached to the surface during these experiments.

Figure 3.8a - d Fluid movement through the flow chamber

CHAPTER 4
DISCUSSION
This laboratory is the first to consider the effects of shear stress on cardiomyocytes in
connection with regulation of the genetic expression of AT1 and AT2 receptors. This
paper reports the preliminary findings and suggests future direction of research. As
reported previously by others, cardiac hypertrophy is mediated by Angiotensin II through
Angiotensin receptors AT1 and AT2. In the current research, procedures were developed
that will allow observation of the effects of shear stress on regulation of the AT1 and
AT2 receptor genes.
The current study reports on two significant achievements in completion of this
task. First, in order to show regulation of ATl and AT2 receptors, the ability to use the
molecular biology techniques of RT-PCR were developed. The rat cardiomyocytes were
successfully isolated, messenger RNA was extracted from these cells and the ability to
consistently carryout RT-PCR to amplify AT1 and AT2 mRNA signals was
demonstrated.
The other achievement includes the ability to attach live cardiomyocytes to a
culture dish used for flow experiments. In order to administer shear stress through the
use of the flow chamber, it was necessary to first successfully attach cardiomyocytes to
the culture dish surface and prevent them from washing away with the flow medium.
Through an incubation procedure, this laboratory has demonstrated the ability to attach
cardiomyocytes to two different surfaces. The polystyrene surface of the culture dish
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from Coming and the membrane of cell culture inserts from B-D were appropriate for
cell attachment.
However, changes can be suggested to yield better results. In the flow chamber
experiments, application of higher shear stresses is desired. However, there are several
hurdles in accomplishing this task. The flow chamber provides some challenges due to
its unstable construction. The components of the flow chamber including the flow
chamber deck, the rubber gasket and culture dish are held together by vacuum. The
slightest movement tends to throw off the equilibrium and causes suction to overwhelm
the system and suction away the content of the chamber. The other challenge in utilizing
the flow chamber is the entry of air bubbles. Even in the most careful techniques, it is
impossible to completely eliminate the entry of air bubbles. The slightest movement of
the chamber causes air bubbles to enter the flow chamber as the airtight junctions
between the gasket and flow chamber deck are temporarily disturbed. Once an air bubble
enters the flow path, it is impossible to extract it. It is also unrealistic to continue with
the experiment as the presence of the air bubble in the flow path prevents shearing of the
cells. The bubble also interferes with normal flow of the medium through the flow path.
The other challenge is the attachment of the cells to the surface. In order to
increase the shear stress through the chamber, it is necessary for the cells to remain
attached. If the cells are not adequately attached to the surface, they tend to flow away
with the medium.
To strengthen cell attachment, two different surfaces were utilized. The first of
these surfaces included the culture grade plastic (culture dish) from Corning. The results
presented here showed that the plastic surface was useful in experiments utilizing flow
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rates in the range of 10-20 ml/hr. Next, a culture membrane from culture inserts was
utilized. The insert membrane is treated with a polymer to strengthen cell adhesion.
Once again the results showed that cell attached best when flow rates of 10-20 ml/hr were
administered.
As far as the challenges posed by the flow chamber, improvements will have to be
made by the manufacturer. Until a better flow chamber is available, careful handling of
the flow chamber is suggested. On the cell attachment side, other options remain. Some
researchers have suggested using various attachment substances and serum mediums that
will allow better cell adhesion.26-28

CHAPTER 5
CONCLUSION AND RECOMMENDATIONS

As discussed above, techniques have been developed to study the correlation between
AT1 and AT2 gene regulation as it relates to the effects of shear stress on
cardiomyocytes. The ability to track genetic regulation of angiotensin receptor through
molecular biology techniques of RT-PCR has been shown. The ability to attach
cardiomyocytes to a culture dish surface in order to subject these cells to shear stress via
the flow chamber apparatus, has also been demonstrated
However, improvements can be made to take full advantage of the flow chamber
apparatus. The central issue of these improvements is being able to get stronger cell
attachments to the culture dish surface. This will increase the number of cells that remain
attached to the dish and the length of time these attachments last. Improvements in the
attachment will also allow higher flow rates to be applied during flow experiments.
Other methods for adhering cardiomyocytes have been published. Mitcheson and
group have suggested a "rapid attachment" method. 26 The method is best for acute
studies that will utilize the cell shortly after isolation. The culture surface is pretreated
and cells are plated in a serum-free medium. The method utilizes laminin (a protein)
diluted between l-5 1.11/ml in phosphate buffered saline. The culture surface is treated at
least 30 minutes prior to plating cells. Other researchers have suggested use of various
attachment substances including laminin, cell culture plastic, elastin, rat tailed collagen
and fibronectin. 27 Use of medium containing foetal bovine or horse serum has also been
suggested. 28

33

REFERENCES
1. Pierre Paradis, Nassim Dali-Youcef, Francois W. Paradis, Gaetan Thibault, Mona
Nemer. Overexpression of angiotensin II type 1 receptor in cardiomyocytes
induces cardiac hypertrophy and remodeling. PNAS. 2000.97(2):931-936.
2.

Borland J, Chester A, Horrison K, Yacoub M. Alternative pathways of
angiotensin II production in the human saphenous vein. Br J Pharmacol
1998;125:423-8.

3. Higake J, Aoki M, Morishita R, Kida I, Taniyama Y, Tomita N, Yamamoto K,
Moriguchi A, Kaneda Y, Ogihara T. In Vivo Evidence of the Importance of
Cardiac Angiotensin-Converting Enzyme in the Pathogenesis of Cardiac
Hypertrophy. Arterioscler Thromb Vasc Biol. 2000;20:428-34.
4.

Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting
enzyme inhibitors on mortality and morbidity in patients with heart failure.
Collaborative Group on ACE inhibitor Trials. JAMA 1995;273:1450-6.

5. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of
ramipril on mortality and morbidity of survivors of acute myocardial
infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
6. Timmermans P, Benfield P, Chiu A, Herblin W, Wong P, and Smith R.
Angiotensin II receptors and functional correlates. Am. J. Hypertens
1992;5:221S-35S.
7. Busche S, Gallinat S, Bohle R, Reinecke A, Seebeck J, Franke F, Fink L, Zhu M,
Sumners C, Unger T. Expression of Angiotensin AT1 and AT2 Receptors in
Adult Rat Cardiomyocytes after Myocardial Infarction. A Single-Cell Reverse
Transcriptase-Polymerase Chain Reaction Study. Am J Pathol 2000; 157:60511.
8. Kestern C, Heugten H, Lamers J, Saxena P, Schalekamp M, Danser A.
Angiotensin II- mediated Growth and Antigrowth Effects in Cultured
J Mol Cell Cardiol
Neonatal Rat Cardiac Myocytes and Fibroblasts.
1997;29:2147-57.
9.

Opie L and Sack M. Enhanced Angiotensin II activity in heart failure:
reevaluation of the counterregulatory hypothesis of receptor subtypes. Circ
Res 2001;88(7):654-658.

10. Schneider M and Lorell B. AT2, Judgment day: which angiotensin receptor is
the culprit in cardiac hypertrophy? Circulation 2001;104(3):247.

35

11. Chang R and Lotti V. Angiotensin receptor subtypes in rat, rabbit and monkey
tissues:
relative distribution and species dependency. Life Sci
1991;49(20):1485-1490.
12. Regitz-Zagrosek V, Friedel, N, Heyman A, Bauer P, NeuB M, Folfs A, Steffan
C, Hilderbrand A, Hetzer R, Fleck E. Regulation, chamber localization, and
subtype distribution of angiotensin II receptors in human hearts. Circulation
1995;91:1461-71.
13. Sechi L, Griffin C, Crady E, Kalinyak J, Schambelan M. Characterization of
angiotensin II receptor subtypes in rat heart. Circ Res 1992;71:1482-9.
14. Rogg h, Schmid A, De Gasparo M.Identification and characterization of
angiotensin II receptor subtypes in rabbit ventricular myocardium. Biochem
Biophys Res Commun 1990;173:416-22.
15. Scott A, Chong R, Lotti V, Siegl P. Cardiac angiotensin receptors; effects of
selective angiotensin II receptor antagonists, DuP753 and PD 121981 in rabbit
heart. J pharmacol Exp Ther 1992;261:931-35.
16. Villarreal F, Kim N, Ungab G, Printz M, Dillmann W. Identification of
functional angiotensin II receptors on rat cardiac fibroblasts. Circulation
1993;88:2849-61.
17. Hunt R, Ciuffo G, Saavedra J, Tucker D. Quantification and localization of
angiotensin II receptors and angiotensin converting enzyme in the developing
rat heart. Cardiovasc Res 1995;29:834-40.
18. Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, Murasawa S, Kijima
K, Maruyama K, Masaki H, Yasutaka M, Shibasaki Y, Kamihata H, Inada M,
Iwasaka T. Angiotensin II type 2 receptor is upregulated in human heart with
interstitial fibrosis, and cardiac fibroblasts are the major cell type for its
expression. Circ Res 1998;83:1035-1046.
19. McWhinney C, Hunt R, Conrad K, Dostal D, Baker K. The Type I Angiotensin
II Receptor Couples to Stat 1 and Stat3 Activation through Jak2 Kinase in
Neonatal Rat Cardiac Myocytes. . J Mol Cell Cardiol 1997;29:2513-24.
20. McWhinney C, Dostal D, Baker K. Angiotensin II Activates Stat5 through Jak2
Kinase in Cardiac Myocytes. J Mol Cell Cardiol 1998;30:751-61.
21. Pan J, Fukida K, Kodama H, Mokino S, Takahashi T, Sano M, Hon S, Ogawa S.
Role of Angiotensin II in activation of the JAK/STAT pathway induced by
acute pressure overload in the rat heart. Circ Res. 1997,81(4):611-617.

36

22. Shao Q, Saward L, Zahradka P, Dhalla N. Ca2+ Mobilization in Adult Rat
Cardiomyocytes by Angiotensin Type 1 and 2 Receptors. Biochem
Pharmacology 1998; 55:1413-8.
23. Kinugawa K, Takahashi T, Kohmoto 0, Yao A, Ikenouchi H, Serizawa T.
Ca2+- growth coupling in angiotensin II- induced hypertrophy in cultured rat
cardiac cells. Cardiovasc Res 1995;30:419-31.
24. Mitra R, Morad M. A uniform enzymatic method for dissociation of myocytes
from hearts and stomachs of vertebrates. Am J Physiol 1985 Nov; 249
(5 Pt 2):H1056-60.
25. Bird B, Stewart W, Lightfoot E. Transport Phenomena. John Wiley & Sons,
Inc., New York, 1960.
26. Micheson J, Hancox J, Levi A. Cultured adult cardiac myocytes: future
applications, culture methods, morphological and electrophysiological
properties. Cariovascular Research.1998; 39:280-300.
27. Jacobson S and Piper H. Cell culture of adult cardiomyocytes as models of the
myocardium. J Mo Cell Cardiol. 1986; 18: 661-678.
28. Piper H, Probst I, Schwartz P, Huffer F, Spieckermann P. Culturing of calcium
stable adult cardiac myocytes. J Mo Cell Cardiol. 1982;14: 397-412.

